FRFarid Rajabli

Farid Rajabli

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Farid Rajabli has a total of 129 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Strategies in Global Ancestry and Local Ancestry Inference

    by Bilcag Akgun, Farid Rajabli

    Genetic ancestry inference has become essential in population and medical genetics, especially for studies of admixed populations. Accurate determination of both global ancestry (GA) proportions and local ancestry (LA) segmental origins requires careful selection of computational methods and reference panels. Here, we present a practical, protocol‐oriented guide that (i) clarifies key concepts (GA vs. LA, reference panel selection, phasing requirements), (ii) organizes methods into model‐based clustering and dimensionality‐reduction approaches for GA and hidden Markov model–based, window‐based machine learning, and deep learning frameworks for LA and (iii) provides concise guidance on tool selection for GA and LA. Step‐by‐step protocols are provided for a typical ADMIXTURE‐based GA analysis and for a SHAPEIT5 + RFMix LA inference pipeline, with practical considerations for genotype array and whole‐genome sequencing data. We also discuss quality control, method validation, and downstream applications of ancestry inference. Finally, we address current challenges and highlight recent advances, including fast algorithms, deep learning models, improved phasing, and integrative tools. This guide aims to help researchers select and implement appropriate ancestry inference methods for diverse study designs and datasets. © 2026 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1 : Global ancestry analysis (ADMIXTURE pipeline) Basic Protocol 2 : Local ancestry analysis (phasing + RFMix pipeline)


  • Open Access

    Genome‐Wide Analysis of Memory, Language, and Executive Function Reveals Domain‐Specific Genetic Architecture in Alzheimer Disease

    by Kyle M Scott, Azra Emekci, Vanessa Aguiar‐Pulido, Farid Rajabli

    Background: Alzheimer disease (AD) involves progressive decline in multiple cognitive domains, including memory, executive function, and language. The genetic underpinnings of these key endophenotypes remain incompletely understood. Variability in neuropsychological assessment batteries across studies has been a major barrier to reproducibility, underscoring the need for standardized measurements. We leverage the Phenotype Harmonization Consortium (PHC) dataset and National Alzheimer's Coordinating Center (NACC) genetic data to perform a genome‐wide association study (GWAS) of these three cognitive domains. Our goal is to clarify the contributions of specific genetic variants to distinct AD endophenotypes and thereby gain deeper insight into the neuropathological processes driving this disease. Method: We conducted a genome‐wide association analysis using data from 7,279 non‐Hispanic White participants from the NACC datasets. Cognitive performance was assessed using harmonized measures of executive function, language, and memory. We employed generalized linear mixed models controlling for age, sex, education, and three principal components to examine associations between genetic variants and cognitive performance Result: We evaluated known AD‐associated loci (Bellenguez et al. 2022) and 27 loci reached nominal significance ( p < 0.05) in at least one cognitive domain. Of these, 8 were nominally significant in exactly one domain, 11 in two domains, and 7 (including APOE4, APOE2, ABCA7, USP6NL, WNT3, CD2AP , and EPDR1 ) in all three domains. Notably, APOE4 displayed the strongest overall effects, with the stronger effect size on memory (BETA_mem = −0.28, p = 1.10×10^−58) and comparatively weaker yet still significant effects on language (BETA_lan = −0.14, p = 2.59×10^−19) and executive function (BETA_exf = −0.12, p = 2.30×10^−17). These results underscore both the broad influence of certain variants across multiple cognitive measures and variation in effect magnitude by domain. Conclusion: These findings enhance our understanding of the biological mechanisms that contribute to domain‐specific cognitive decline in AD, underscoring the distinct processes driving deficits in memory, language, and executive function. Such insights pave the way for more precise, syndrome‐focused interventions, ultimately guiding a precision medicine approach tailored to the heterogeneous clinical manifestations of AD.

  • Open Access

    Country-level incidence of Alzheimer disease and related dementias is associated with increased omega-6-PUFA consumption

    by Timothy H. Ciesielski, Giuseppe Tosto, Razaq O. Durodoye, Farid Rajabli, Rufus O. Akinyemi, Goldie S. Byrd, William S. Bush, Brian W. Kunkle, Christiane Reitz, Jeffery M. Vance, et al.

    Background: Clinical and genetic studies have implicated lipid dysfunction in Alzheimer Disease (AD) pathogenesis. While the etiologic impact of lipid intake on individuals is receiving attention, the role of food systems in shaping community-level incidence remains uncharacterized. Methods: Mean country-level lipid intakes were compared to Age-Standardized Alzheimer-and-other-Dementia Incidence Rates (ASAIR) in 183 countries across all inhabited continents. Free-knot penalized spline regression and multivariable-adjusted linear regression, including a lag between intake and incidence, were used to assess the relationships between five lipid intakes and ASAIR. Validation was conducted using longitudinal within-country changes between 1990 and 2019. Results: Here we show that omega-6 Polyunsaturated-Fatty-Acid (omega-6) intake exhibits a positive linear relationship with ASAIR (multivariable-adjusted model: β = 2.44; 95%CI: 1.70, 3.19; p = 1.38 × 10−9). ASAIR also increases with saturated-fat, trans-fat, and dietary-cholesterol up to a threshold. The association between omega6-PUFA and ASAIR is confirmed using longitudinal intake changes. The scale of predicted benefits varies by country but, our results predict a 2 standard deviation decrease (−3.8% as a percent of daily energy intake) in omega-6 intake would reduce ASAIR by 8% in the US. This level of consumption has already been achieved in 20 countries. If our other findings are validated in future work, decreasing all four lipids could potentially yield large ASAIR reductions (in the US: a 35% decrease). Conclusions: Higher levels of omega-6 consumption associate with increased ASAIR. Thus, decreasing omega-6 consumption on the country-level may have substantial benefits in reducing the burden of dementia.


  • Open Access

    Comparing Alzheimer's genes in African, European, and Amerindian induced pluripotent stem cell–derived microglia

    by Sofia Moura, Luciana Bertholim Nasciben, Aura M. Ramirez, Lauren Coombs, Joe Rivero, Derek J. Van Booven, Brooke A. DeRosa, Kara L. Hamilton‐Nelson, Patrice L. Whitehead, Larry D. Adams, et al.

    INTRODUCTION: Genome‐wide association studies (GWAS) studies in Alzheimer's disease (AD) demonstrate ancestry‐specific loci. Previous studies in the regulatory architecture have only been conducted in Europeans (EUs), thus studies in additional ancestries are needed. Given the prevalence of AD genes expressed in microglia, we initiated our studies in induced pluripotent stem cell (iPSC) ‐derived microglia. METHODS: We created iPSC‐derived microglia from 13 individuals of either high Amerindian (AI), African (AF), or EU global ancestry, including both AD and controls. RNA‐seq, ATAC‐seq, and pathway analyses were compared between ancestries in both AD and non‐AD genes. RESULTS: Twelve AD genes were differentially expressed genes (DEGs) and/or accessible between ancestries, including ABI3 , CTSB , and MS4A6A . A total of 5% of all genes had differential ancestral expression, but differences in accessibility were less than 1%. The DEGs were enriched in known AD pathways. DISCUSSION: This resource will be valuable in evaluating AD in admixed populations and other neurological disorders and understanding the AD risk differences between populations. Highlights: First comparison of the genomics of AI, AF, and EU microglia. Report differences in expression and accessibility of AD genes between ancestries. Ancestral expression differences are greater than differences in accessibility. Good transcriptome correlation was seen between brain and iPSC‐derived microglia. Differentially expressed AD genes were in known AD pathways.


  • Open Access

    Enhancing Alzheimer Disease risk prediction using machine learning for Pathway Polygenic Risk Scores (p‐PRS)

    by Farid Rajabli, Vanessa Aguiar‐Pulido, Kyle Scott, Briseida E. Feliciano‐Astacio, Kara L. Hamilton‐Nelson, Larry D. Adams, Pedro R. Mena, Katrina Celis, Jose Javier Sanchez, Patrice L. Whitehead, et al.

    Background: Polygenic Risk Scores (PRS) are important in predicting disease risk and are usually rely on markers selected by thresholding p‐values from genome‐wide association studies (GWAS). In traditional approaches, one single model is built to calculate risk scores, employing effect size to determine additive risk. However, this traditional method overlooks potential interactions between genetic loci resulting in reduced prediction power. To overcome these limitations, we propose an interpretable machine learning approach based on pathway‐level PRS (p‐PRS). Our approach improves prediction accuracy of PRS and generates both pathway specific and overall PRS considering possible nonlinear interactions. This advancement opens new avenues in personalized medicine, enabling more accurate disease prediction and prevention strategies.Method: We used whole genome sequencing data from 652 individuals from the Puerto Rican Alzheimer’s Disease Initiative (PRADI). First, we selected Alzheimer disease (AD)‐related pathways and genes based on those reported in the largest non‐Hispanic White AD GWAS to date (Bellinguez et al. 2021). Then, we applied the Clumping and Thresholding (C+T) PRS approach using Bellinguez et al. summary statistics within each pathway (±20Kb for each gene). Finally, we used random forest with pathway‐level PRS values as input to classify AD vs. control. We assessed the performance of the p‐PRS model based on area under the receiver operating characteristic curve (AUC) using a 70%/30% split for training/testing. The outcomes were compared to a traditional C+T PRS model (AD∼PRS+APOE).Result: p‐PRS improves the performance of the traditional PRS model by 4.2% (p = 5.54E‐32). Performance is centered around AUC = 0.689(SE = 0.0022) for p‐PRS and 0.647(SE = 0.0024) for traditional PRS. PRS by pathway enables determining individual‐level important pathways for accurate classification. Top pathways obtained are related to processes implicated in cognitive deficit, neuroinflammation, neurodegeneration and vesicle mediation.Conclusion: Utilizing the innovative p‐PRS approach has improved the estimation of AD risk in the PR cohort. The application of interpretable machine learning approaches allows identifying the most relevant pathways for effective risk prediction and classification. Importantly, improved precision will provide more effective actionable risk mitigation strategies, optimize the selection process for clinical trials, and contribute to the development of more personalized treatment interventions.


  • Open Access

    Gene expression and chromatin accessibility comparison in iPSC-derived microglia in African, European, and Amerindian genomes in Alzheimer’s patients and controls

    by Sofia Moura, Luciana Bertholim Nasciben, Aura M. Ramirez, Lauren Coombs, Joe Rivero, Derek J. Van Booven, Brooke A. DeRosa, Kara L. Hamilton-Nelson, Patrice L. Whitehead, Larry D. Adams, et al.

    Alzheimer’s disease (AD) risk differs between population groups, with African Americans and Hispanics being the most affected groups compared to non-Hispanic Whites. Genetic factors contribute significant risk to AD, but the genetic regulatory architectures (GRA) have primarily been studied in Europeans. Many AD genes are expressed in microglia; thus, we explored the impact of genetic ancestry (Amerindian (AI), African (AF), and European (EU)) on the GRA in iPSC-derived microglia from 13 individuals (∼4 each with high global ancestry, AD and controls) through ATAC-seq and RNA-seq analyses. We identified several differentially accessible and expressed genes (2 and 10 AD-related, respectively) between ancestry groups. We also found a high correlation between the transcriptomes of iPSC-derived and brain microglia, supporting their use in human studies. This study provides valuable insights into genetically diverse microglia beyond the analysis of AD.

  • Open Access

    Addressing overlapping sample challenges in genome-wide association studies: Meta-reductive approach

    by Farid Rajabli, Azra Emekci

    Polygenic risk scores (PRS) are instrumental in genetics, offering insights into an individual level genetic risk to a range of diseases based on accumulated genetic variations. These scores rely on Genome-Wide Association Studies (GWAS). However, precision in PRS is often challenged by the requirement of extensive sample sizes and the potential for overlapping datasets that can inflate PRS calculations. In this study, we present a novel methodology, Meta-Reductive Approach (MRA), that was derived algebraically to adjust GWAS results, aiming to neutralize the influence of select cohorts. Our approach recalibrates summary statistics using algebraic derivations. Validating our technique with datasets from Alzheimer disease studies, we showed that the summary statistics of the MRA and those derived from individual-level data yielded the exact same values. This innovative method offers a promising avenue for enhancing the accuracy of PRS, especially when derived from meta-analyzed GWAS data.

  • Open Access

    African Ancestry Individuals with Higher Educational Attainment Are Resilient to Alzheimer’s Disease Measured by pTau181

    by Farid Rajabli, Azizi A. Seixas, Bilcag Akgun, Larry D. Adams, Jovita Inciute, Kara L. Hamilton, Patrice G. Whithead, Ioanna Konidari, Tianjie Gu, Jamie Arvizu, et al.

    Background: Cognitive and functional abilities in individuals with Alzheimer’s disease (AD) pathology (ADP) are highly variable. Factors contributing to this variability are not well understood. Previous research indicates that higher educational attainment (EA) correlates with reduced cognitive impairments among those with ADP. While cognitive and functional impairments are correlated, they are distinguishable in their manifestations. Objective: To investigate whether levels of education are associated with functional impairments among those with ADP. Methods: This research involved 410 African American (AA) individuals (Institutional Review Boards 20070307, 01/27/2023) to ascertain whether EA correlates with functional resilience and if this effect varies between APOE ɛ4 carriers and non-carriers. Utilizing EA as a cognitive reserve proxy, CDR-FUNC as a functional difficulties measure, and blood pTau181 as an ADP proxy, the non-parametric Mann-Whitney U test assessed the relationship between EA and CDR-FUNC in individuals with advanced pTau181 levels. Results: The results showed that EA correlated with functional difficulties in AA individuals with high levels of pTau181, such that individuals with high EA are more likely to have better functional ability compared to those with lower EA (W = 730.5, p = 0.0007). Additionally, we found that the effect of high EA on functional resilience was stronger in ɛ4 non-carriers compared to ɛ4 carriers (W = 555.5, p = 0.022). Conclusion: This study extends the role of cognitive reserve and EA to functional performance showing that cognitive reserve influences the association between ADP burden and functional difficulties. Interestingly, this protective effect seems less pronounced in carriers of the strong genetic risk allele ɛ4.


  • Open Access

    MCI in Caribbean Hispanics shows increased impairment in attention and working memory domains relative to non‐Hispanic White individuals

    by Katalina McInerney, Andrew Zaman, Pedro R. Mena, Larry D. Adams, Sergio J. Tejada, Jose Javier Sanchez, Katrina Celis, Kara L. Hamilton‐Nelson, Briseida E. Feliciano‐Astacio, Farid Rajabli, et al.

    Background: Patterns of cognitive performance associated with different stages of dementia have been primarily studied in Non‐Hispanic White (NHW) populations. This study compares patterns of cognitive performance, on a brief neuropsychological battery, in Caribbean Hispanic (CH) and NHW individuals with mild cognitive impairment, based on Clinical Dementia Rating (CDR) staging scores.Method: Our data included 427 individuals including 299 self‐identified CH (mean age = 76.0; 69.6% female; mean education = 11.9) and 128 NHW (mean age = 72.9; 61.7% female; mean education = 13.8) who completed the CDR and a brief neuropsychological battery. Participants with other medical conditions known to impact cognition were excluded. Sex‐, age‐, and education‐adjusted Z‐scores were calculated for all cognitive tests (Logical Memory (Immediate and Delayed recall), Digit Span (Forward and Backward), and Verbal Fluency (Animals and Vegetables)). ANOVAs were used to examine the effects of ethnicity (NHW, CH) and CDR Global Score (0.5, 1.0) on the adjusted Z‐scores for all cognitive tests. CDR score distribution was adjusted through factorial ANOVA (ethnicity x CDR). Descriptive analyses included independent t‐tests to examine differences between ethnicity groups on age, sex, education, percent AD, percent Unclear, and CDR Global Score.Result: There was a main effect of ethnicity on Digit Span Forward (p < 0.001), Digit Span Backward (p < 0.001), and Verbal Fluency – Vegetables (p < 0.01), where CH individuals showed greater impairment regardless of Global CDR score. We found a main effect of Global CDR score on all cognitive tests, where individuals with Global CDR score of 1.0 demonstrated more impairment than individuals with a Global CDR score of 0.5. No ethnicity x CDR interactions were significant.Conclusion: Our sample of older CH and NHW individuals, presumed to have mild cognitive impairments based on CDR staging, did not differ in memory abilities. However, the CH group scored significantly lower on measures of attention and working memory. Finally, semantic fluency performance was variable and possibly influenced by cultural familiarity with different semantic categories. Among older CH individuals with mild dementia, cognitive difficulties may extend beyond memory problems and include attentional and executive function difficulties. These findings have clinical implications for diagnosis and management of CH patients.

  • Open Access

    Addressing Overlapping Sample Challenges in Genome-Wide Association Studies: Meta-Reductive Approach

    by Farid Rajabli

    Polygenic risk scores (PRS) are instrumental in genetics, offering insights into an individual level genetic risk to a range of diseases based on accumulated genetic variations. These scores rely on Genome-Wide Association Studies (GWAS). However, precision in PRS is often challenged by the requirement of extensive sample sizes and the potential for overlapping datasets that can inflate PRS calculations. In this study, we present a novel methodology, Meta-Reductive Approach (MRA), that was derived algebraically to adjust GWAS results, aiming to neutralize the influence of select cohorts. Our approach recalibrates summary statistics using algebraic derivations. Validating our technique with datasets from Alzheimer’s disease studies, we showed perfect correlation between summary statistics of proposed approach and “leave-one-out” strategy. This innovative method offers a promising avenue for enhancing the accuracy of PRS, especially when derived from meta-analyzed GWAS data. Availability and implementation MRA script is freely available at https://github.com/hihg-um/MRA as an R function.